Sunshine and rash: testing the role of sunscreen to prevent epidermal growth factor receptor inhibitor-induced rash.
Most patients who receive epidermal growth factor receptor (EGFR) inhibitors develop a rash. To date, no effective palliative therapy has been developed for these rashes. This review describes the rationale behind N05C4, a placebo-controlled trial of sunscreen as an intervention to prevent EGFR inhibitor-related rash.
Jatoi
Aminah
A
Department of Oncology, Mayo Clinic, Rochester, MN.